{"version":"1.0","type":"link","title":"Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxel.","author_name":"Shibuki T 외","author_url":"https://prs-insight.online/author/Shibuki%20T","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/157111","thumbnail_width":1200,"thumbnail_height":630}